Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Effects of transdermal testosterone treatment on inflammatory markers in elderly males.

Maggio M, Snyder PJ, De Vita F, Ceda GP, Milaneschi Y, Lauretani F, Luci M, Cattabiani C, Peachey H, Valenti G, Cappola AR, Longo DL, Ferrucci L.

Endocr Pract. 2014 Nov;20(11):1170-7. doi: 10.4158/EP13357.OR.

2.

Effects of testosterone and growth hormone on the structural and mechanical properties of bone by micro-MRI in the distal tibia of men with hypopituitarism.

Al Mukaddam M, Rajapakse CS, Bhagat YA, Wehrli FW, Guo W, Peachey H, LeBeau SO, Zemel BS, Wang C, Swerdloff RS, Kapoor SC, Snyder PJ.

J Clin Endocrinol Metab. 2014 Apr;99(4):1236-44. doi: 10.1210/jc.2013-3665. Epub 2014 Jan 13.

3.

Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.

Maggio M, Snyder PJ, Ceda GP, Milaneschi Y, Luci M, Cattabiani C, Masoni S, Vignali A, Volpi R, Lauretani F, Peachey H, Valenti G, Cappola AR, Longo D, Ferrucci L.

Andrology. 2013 Jan;1(1):24-8. doi: 10.1111/j.2047-2927.2012.00009.x. Epub 2012 Oct 9.

4.

A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors.

Pacey S, Wilson RH, Walton M, Eatock MM, Hardcastle A, Zetterlund A, Arkenau HT, Moreno-Farre J, Banerji U, Roels B, Peachey H, Aherne W, de Bono JS, Raynaud F, Workman P, Judson I.

Clin Cancer Res. 2011 Mar 15;17(6):1561-70. doi: 10.1158/1078-0432.CCR-10-1927. Epub 2011 Jan 28. Erratum in: Clin Cancer Res. 2018 Nov 1;24(21):5488.

5.

In vivo magnetic resonance detects rapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol.

Wehrli FW, Ladinsky GA, Jones C, Benito M, Magland J, Vasilic B, Popescu AM, Zemel B, Cucchiara AJ, Wright AC, Song HK, Saha PK, Peachey H, Snyder PJ.

J Bone Miner Res. 2008 May;23(5):730-40. doi: 10.1359/jbmr.080108.

6.

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

Snyder PJ, Peachey H, Berlin JA, Rader D, Usher D, Loh L, Hannoush P, Dlewati A, Holmes JH, Santanna J, Strom BL.

Am J Med. 2001 Sep;111(4):255-60.

PMID:
11566454
7.

Effects of testosterone replacement in hypogonadal men.

Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL.

J Clin Endocrinol Metab. 2000 Aug;85(8):2670-7.

PMID:
10946864
8.

Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age.

Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL.

J Clin Endocrinol Metab. 1999 Aug;84(8):2647-53.

PMID:
10443654
9.

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL.

J Clin Endocrinol Metab. 1999 Jun;84(6):1966-72.

PMID:
10372695

Supplemental Content

Loading ...
Support Center